1. Babu M, Devi T, Kaikkonen M, Mäkinen P, Laakso H, Liimatainen T, Velagapudi V, Glass CK, Ylä-Herttuala S. Altered macrophage phenotypic transition correlates with impaired vascular growth responses in diabetic mouse model of hindlimb ischemia. Manuscript. 2020.

2. Aavik E, Babu M, Ylä-Herttuala S. DNA methylation processes in atherosclerotic plaque. Atherosclerosis 281 (2019) 168–179.

3. A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes. https://doi.org/10.2337/db17-0914 (2018) (part of SUMMIT consortium).

4. Devi T *, Babu M *, Mäkinen P, Kaikkonen M, Heinoniemi M, Laakso H, Ylä-Herttuala E, Rieppo L, Liimatainen T, Naumenko N, Tavi P, Ylä-Herttuala S. Aggravated post-infarct heart failure in type 2 diabetes is associated with impaired mitophagy and exaggerated inflammasome activation. (* Shared first author). Am J Pathol. 2017:187: 2659-2673.

5. Babu M, Devi T, Mäkinen P, Kaikkonen M, Lesch H, Junttila S, Laiho A, Ghimire B, Gyenesei A, Yla-Herttuala S. Differential promoter methylation of macrophage genes is associated with impaired vascular growth in ischemic muscles of hyperlipidemic and type 2 diabetic mice: A Genome-Wide Promoter Methylation Study. Circulation Research. 2015;117:289–299.

6. Bhardwaj S, Roy H, Babu M, Shibuya M, Yla-Herttuala S. Adventitial gene transfer of VEGFR-2 specific VEGF-E chimera induces MCP-1 expression in vascular smooth muscle cells and enhances neointimal formation. Atherosclerosis. 2011; 219(1): 84-91.

7. Roy H, Bhardwaj S, Babu M, Lähteenvuo J, Ylä-Herttuala S. VEGF-D∆N∆C Mediated Angiogenesis in Skeletal Muscles of Diabetic WHHL Rabbits. Eur J Clin Invest. 2010; 40(5): 422-32.

8. Viita H, Kinnunen K, Eriksson E, Lähteenvuo J, Babu M, Kalesnykas G, Heikura T, Laidinen S, Takalo T, Ylä-Herttuala S. Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes. Hum Gene Ther. 2009; 20(12): 1679-86.

9. Viita H, Markkanen J, Eriksson E, Nurminen M, Kinnunen K, Babu M, Heikura T, Turpeinen S, Laidinen S, Takalo T, Ylä-Herttuala S. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and down regulation of VEGF receptor 2 expression. Circulation Research. 2008; 102(2): 177-84.

10. Räty S, Piironen A, Babu M, Pelli H , Sand J, Uotila S, Nordback I, Herzig KH. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish hereditary pancreatitis family. Scand J Gastroenterol. 2007; 42(8):1000-5.

11. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T, Laitinen T, Hakumaki J, Laakso M, Herzig KH, Yla-Herttuala S. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J. 2006; 20(12):2159-61.

12. Roy H, Bhardwaj S, Babu M, Jauhiainen S, Herzig KH, Haisma HJ, Carmeliet P, Alitalo K, Ylä-Herttuala S . Adenovirus mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via up regulation of the expression of endogenous vascular endothelial growth factor-A. Human Gene Therapy. 2005; 16(12):1422-8.

13. Kumar A, Babu M, Kimberling WJ, Venkatesh CP. Genetic analysis of a four-generation Indian family with Usher syndrome: a novel insertion mutation in MYO7A. Molecular Vision. 2004; 10:910-6.

14. Kumar A, Babu M, Raghunath A, Venkatesh CP. Genetic analysis of a five generation Indian family with BPES: A novel missense mutation (p. Y215C). Molecular Vision. 2004; 10:445-9.

15. Kumar A, Blanton SH, Babu M, Markandaya M, Girimaji SC.Genetic analysis of primary microcephaly in Indian families: novel ASPM mutations. Clin Genet. 2004; 66(4):341-8.